Want To Bet On Ozempic, Wegovy Success? Defiance Introduces Leveraged ETF To Capture Novo Nordisk Momentum

On Tuesday, Defiance ETFs introduced NVOX, the first single-stock leveraged ETF focused on Danish pharmaceutical giant Novo Nordisk A/S NVO. The ETF offers retail investors double the daily long exposure to Novo Nordisk's stock price changes without requiring a margin account, presenting an innovative trading option. However, NVOX carries heightened risk due to its single-stock nature and does not invest directly in Novo Nordisk shares. Also Read: Big Pharma Pushes To Revise Biden-era Medicare Drug Price Ne ...